|
Peptide Name
|
CAT#
|
Peptide Sequence
|
|
HBV Seq1 aa: 141-151
|
1972-2-1
|
Ser-Thr-Leu-Pro-Glu-Thr-Thr-Val-Val-Arg-Arg
|
|
HBV Seq1 aa: 18-27
|
1972-2-2
|
Phe-Leu-Pro-Ser-Asp-Phe-Phe-Pro-Ser-Val
|
|
HBV Seq1 aa: 63-71
|
1972-2-3
|
Gly-Glu-Leu-Met-Thr-Leu-Ala-Thr-Trp
|
|
HBV Seq1 aa: 93-100
|
1972-2-4
|
Met-Gly-Leu-Lys-Ile-Arg-Gln-Leu
|
|
HBV Seq2 aa: 179-186
|
1972-2-5
|
Phe-Val-Gln-Trp-Phe-Val-Gly-Leu
|
|
HBV Seq2 aa: 208-216
|
1972-2-6
|
Ile-Val-Ser-Pro-Phe-Ile-Pro-Leu-Leu
|
|
HBV Seq2 aa: 208-216
|
1972-2-7
|
Ile-Leu-Ser-Pro-Phe-Leu-Pro-Leu-Leu
|
|
HBV Seq2 aa: 28-39
|
1972-2-8
|
Ile-Pro-Gln-Ser-Leu-Asp-Ser-Trp-Trp-Thr-Ser-Leu
|
|
Hepatitis B Virus Pre-S Region (120-145)
|
1972-2-9
|
Met-Gln-Trp-Asn-Ser-Thr-Thr-Phe-His-Gln-Thr-Leu-Gln-Asp-Pro-Arg-Val-Arg-Gly-Leu-Tyr-Phe-Pro-Ala-Gly-Gly
|
|
Hepatitis B Virus Receptor Binding Fragment
|
1972-2-10
|
Pro-Leu-Gly-Phe-Phe-Pro-Asp-His-Gln-Leu-Asp-Pro-Ala-Phe-Gly-Ala-Asn-Ser-Asn-Asn-Pro-Asp-Trp-Asp-Phe-Asn-Pro
|
|
[Ala127] Hepatitis B Virus Pre-S Region (120-131)
|
1972-2-11
|
Met-Gln-Trp-Asn-Ser-Thr-Ala-Phe-His-Gln-Thr
|
|
Ac-Asp-DGla-Leu-Ile-b-cyclohexyl-Ala-Cys
|
1972-2-12
|
Ac-Asp-DGla-Leu-Ile-Cha-Cys
|
|
Ac-Glu-Glu-Val-Val-Ala-Cys-AMC
|
1972-2-13
|
Ac-Glu-Glu-Val-Val-Ala-Cys-AMC
|
|
Ac-Glu-Glu-Val-Val-Ala-Cys-pNA
|
1972-2-14
|
Ac-Glu-Glu-Val-Val-Ala-Cys-pNA
|
|
Glu-Ala-Gly-Asp-Asp-Ile-Val-Pro-Cys-Ser-Met-Ser-Tyr-Thr-Trp-Thr-Gly-Ala
|
1972-2-15
|
Glu-Ala-Gly-Asp-Asp-Ile-Val-Pro-Cys-Ser-Met-Ser-Tyr-Thr-Trp-Thr-Gly-Ala
|
|
HCV Core Protein (107-114)
|
1972-2-16
|
Trp-Gly-Pro-Asn-Asp-Pro-Arg-Arg
|
|
HCV Core Protein (19-25)
|
1972-2-17
|
Pro-Gln-Asp-Val-Lys-Phe-Pro
|
|
HCV Core Protein (59-68)
|
1972-2-18
|
Arg-Gly-Arg-Arg-Gln-Pro-Ile-Pro-Lys-Ala
|
|
HCV NS4A Protein (18-40) (JT strain)
|
1972-2-19
|
Leu-Thr-Thr-Gly-Ser-Val-Val-Ile-Val-Gly-Arg-Ile-Ile-Leu-Ser-Gly-Arg-Pro-Ala-Val-Val-Pro-Asp
|
|
HCV NS4A Protein (21-34) (JT strain)
|
1972-2-20
|
Gly-Ser-Val-Val-Ile-Val-Gly-Arg-Ile-Ile-Leu-Ser-Gly-Arg
|
|
HCV Peptide Aa: 257-266
|
1972-2-21
|
Thr-Ile-Arg-Arg-His-Val-Asp-Leu-Leu-Val
|
|
HCV Peptide Aa: 35-44
|
1972-2-22
|
Tyr-Leu-Leu-Pro-Arg-Arg-Gly-Pro-Arg-Leu
|
|
HCV Peptide Aa:131-140
|
1972-2-23
|
Ala-Asp-Leu-Met-Gly-Tyr-Ile-Pro-Leu-Val
|
|
HCV-1 e2 Protein (484-499)
|
1972-2-24
|
Pro-Tyr-Cys-Trp-His-Tyr-Pro-Pro-Lys-Pro-Cys-Gly-Ile-Val-Pro-Ala
|
|
HCV-1 e2 Protein (554-569)
|
1972-2-25
|
Trp-Met-Asn-Ser-Thr-Gly-Phe-Thr-Lys-Val-Cys-Gly-Ala-Pro-Pro-Cys
|
|
Lys(biotinyl)-Lys-Glu-Asp-Val-Val-Abu-Cys-Ser-Abu-Ser-Tyr-Lys-Lys-NH2
|
1972-2-26
|
Lys(biotinyl)-Lys-Glu-Asp-Val-Val-Abu-Cys-Ser-Abu-Ser-Tyr-Lys-Lys-NH2
|
|
Lys-Lys-Glu-Asp-Val-Val-Abu-Cys
|
1972-2-27
|
Lys-Lys-Glu-Asp-Val-Val-Abu-Cys
|
|
Lys-Lys-Glu-Asp-Val-Val-Abu-Cys-Ser-Abu-Ser-Tyr-Lys-Lys-NH2
|
1972-2-28
|
Lys-Lys-Glu-Asp-Val-Val-Abu-Cys-Ser-Abu-Ser-Tyr-Lys-Lys-NH2
|
|
Mca-Glu-Asp-Ala-Ser-Thr-Pro-Cys-OH
|
1972-2-29
|
Mca-Glu-Asp-Ala-Ser-Thr-Pro-Cys
|
|
Mca-Glu-Asp-Ala-Ser-Thr-Pro-Cys-Ser-Gly-Ser-p-nitro-Phe-Leu
|
1972-3-1
|
Mca-Glu-Asp-Ala-Ser-Thr-Pro-Cys-Ser-Gly-Ser-(NO2)Phe-Leu
|
|
Mca-Lys-Lys-Glu-Asp-Val-Val-Abu-Cys
|
1972-3-2
|
Mca-Lys-Lys-Glu-Asp-Val-Val-Abu-Cys
|
|
Mca-Lys-Lys-Glu-Asp-Val-Val-Abu-Cys-Ser-Abu-Ser-p-nitro-Phe-Lys-Lys-NH2
|
1972-3-3
|
Mca-Lys-Lys-Glu-Asp-Val-Val-Abu-Cys-Ser-Abu-Ser-(NO2)Phe-Lys-Lys-NH2
|
|
Ser-Abu-Ser-Tyr-Lys-Lys-NH2
|
1972-3-4
|
Ser-Abu-Ser-Tyr-Lys-Lys-NH2
|
|
Ser-Gly-Ser-p-nitro-Phe-Leu
|
1972-3-5
|
Ser-Gly-Ser-(NO2)Phe-Leu
|
|
2F5 epitope
|
1972-3-6
|
Glu-Leu-Leu-Glu-Leu-Asp-Lys-Trp-Ala-Ser-Leu-Trp-Asn
|
|
Ac-Ser-Gln-Asn-Tyr-Pro-Val-Val-NH2
|
1972-3-7
|
Ac-Ser-Gln-Asn-Tyr-Pro-Val-Val-NH2
|
|
Alloferon 1
|
1972-3-8
|
His-Gly-Val-Ser-Gly-His-Gly-Gln-His-Gly-Val-His-Gly
|
|
Alloferon 2
|
1972-3-9
|
Gly-Val-Ser-Gly-His-Gly-Gln-His-Gly-Val-His-Gly
|
|
DABCYL-y-Abu-Ser-Gln-Asn-Tyr-Pro-Ile-Val-Gln-EDANS
|
1972-3-10
|
4-(4-Dimethylaminophenylazo)benzoyl-γ-Abu-Ser-Gln-Asn-Tyr-Pro-Ile-Val-Gln-5-[(2-aminoethyl)amino]-naphthalene-1-sulfonic acid
|
|
ELDKWA
|
1972-3-11
|
Glu-Leu-Asp-Lys-Trp-Ala
|
|
Herpes Virus Inhibitor 1
|
1972-3-12
|
Tyr-Ala-Gly-Ala-Val-Val-Asn-Asp-Leu
|
|
Herpes Virus Inhibitor 2
|
1972-3-13
|
Tyr-Gly-Ala-Val-Val-Asn-Asp-Leu
|
|
HIV (gp120) (318-327)
|
1972-3-14
|
Arg-Gly-Pro-Gly-Arg-Ala-Phe-Val-Thr-Ile
|
|
HIV Envelope Protein (254-274)
|
1972-3-15
|
Cys-Thr-His-Gly-Ile-Arg-Pro-Val-Val-Ser-Thr-Gln-Leu-Leu-Leu-Asn-Gly-Ser-Leu-Ala-Glu
|
|
HIV Gag (129-135 )
|
1972-3-16
|
Ser-Glu-Asn-Tyr-Pro-Ile-Val
|
|
HIV Substrate
|
1972-3-17
|
Lys-Ala-Arg-Val-Nle-Phe(NO2)-Glu-Ala-Nle-NH2
|
|
Peptide T
|
1972-3-18
|
Ala-Ser-Thr-Thr-Thr-Asn-Tyr-Thr
|
|
R15K, HIV-1 Inhibitory Peptide
|
1972-3-19
|
Arg-Ile-Gln-Arg-Gly-Pro-Gly-Arg-Ala-Phe-Val-Thr-Ile-Gly-Lys
|
|
[3,5 Diiodo-Tyr7] Peptide T
|
1972-3-20
|
Ala-Ser-Thr-Thr-Thr-Asn-(3,5 diiodo)Tyr-Thr
|
|
[Cys(Bzl)84] CD (81-92)
|
1972-3-21
|
Thr-Tyr-Ile-Cys(benzyl)-Glu-Val-Glu-Asp-Gln-Lys-Glu-Glu
|
|
[DAla1] Peptide T, amide
|
1972-3-22
|
DAla-Ser-Thr-Thr-Thr-Asn-Tyr-Thr-NH2
|
|
gp120, HIV-1 MN
|
1972-3-23
|
Tyr-Asn-Ala-Lys-Arg-Lys-Arg-Ile-His-Ile-Gln-Arg-Gly-Pro-Gly-Arg-Ala-Phe-Tyr-Thr-Thr-Lys-Asn-Ile-Ile
|
|
gp38
|
1972-3-24
|
Arg-Val-Thr-Ala-Ile-Glu-Lys-Tyr-Leu-Gln-Asp-Gln-Ala-Arg-Leu-Asn-Ser-Trp-Gly-Cys-Ala-Phe-Arg-Gln-Val-Cys
|
|
HA Peptide
|
1972-3-25
|
Tyr-Pro-Tyr-Asp-Val-Pro-Asp-Tyr-Ala
|
|
HIV-1, HIV-2 Protease Substrate
|
1972-3-26
|
Ala-Thr-Leu-Asn-Phe-Pro-Ile-Ser-Pro-Trp
|
|
Lactalbumin B (50-53) Alpha [Lactorphin Alpha], bovine
|
1972-3-27
|
Tyr-Gly-Leu-Phe
|
|
VSV-G Peptide
|
1972-3-28
|
Tyr-Thr-Asp-Ile-Glu-Met-Asn-Arg-Leu-Gly-Lys
|
